PharmaSGP Holding SE

Equities

PSG

DE000A2P4LJ5

Pharmaceuticals

Market Closed - Xetra Other stock markets 11:36:07 2024-05-03 am EDT			5-day change	1st Jan Change
23 ^EUR	+2.68%		+3.60%	+2.22%

Apr. 29	PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 18	PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023	CI

PharmaSGP Holding SE Provides Earnings Guidance for 2021

May 18, 2021 at 01:30 am EDT

PharmaSGP Holding SE provided earnings guidance for 2021. For the period, The company anticipates revenues of between EUR 56 million and EUR 60 million.

Latest news about PharmaSGP Holding SE

PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023	Apr. 18	CI
PharmaSGP Holding SE Announces Changes to Dividend Policy	Apr. 18	CI
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 29	CI
Tranche Update on PharmaSGP Holding SE's Equity Buyback Plan announced on January 9, 2023.	23-09-27	CI
PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-27	CI
PharmaSGP Completes EUR2 Million Share Buyback Program	23-07-11	MT
PharmaSGP Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-25	CI
PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
PharmaSGP Holding SE commences an Equity Buyback Plan, under the authorization approved on May 28, 2020.	23-01-09	CI
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2022	22-11-29	CI
PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-28	CI
PharmaSGP Holding SE Reaffirms Earnings Guidance for the Year 2022	22-09-01	CI
PharmaSGP Holding SE Provides Earnings Guidance for the Fiscal Year 2022	22-06-15	CI
PharmaSGP Holding SE Approves Dividend	22-06-15	CI
PharmaSGP Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-31	CI
PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
PharmaSGP Holding SE Provides Revenues Guidance for the Financial Year 2022	22-04-25	CI
PharmaSGP Proposes Dividend for 2021	22-04-04	CI
PharmaSGP Announces Revenue Results for the Financial Year 2021	22-02-17	CI
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2021	21-11-30	CI
PharmaSGP Holding SE Announces Financial Results for the First Half of 2021	21-09-16	CI
PharmaSGP Holding SE Raises Financial Forecast for Fiscal Year 2021	21-09-15	CI
PharmaSGP : GSK Closes Sale of Four OTC Brands to PharmaSGP	21-08-31	MT
Certain Bearer Shares of PharmaSGP Holding SE are subject to a Lock-Up Agreement Ending on 20-JUN-2021.	21-06-19	CI

Chart PharmaSGP Holding SE

Duration

Period

More charts

Company Profile

PharmaSGP Holding SE is a Germany based company, which operates as a pharmaceutical company. The Company produces and develops non-chemical and over-the-counter drugs and other healthcare products.

Sector

Pharmaceuticals

Calendar

2024-05-13 - Q1 2024 Sales and Revenue Release

More about the company

Income Statement Evolution

More financial data

Ratings for PharmaSGP Holding SE

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

23 EUR

Average target price

37 EUR

Spread / Average Target

+60.87%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PHARMASGP HOLDING SE	+2.22%	297M
NOVO NORDISK A/S	+21.85%	546B
JOHNSON & JOHNSON	-4.77%	359B
MERCK & CO., INC.	+16.97%	323B
ABBVIE INC.	+5.69%	290B
ASTRAZENECA PLC	+13.68%	234B
NOVARTIS AG	+3.65%	198B
ROCHE HOLDING AG	-11.12%	194B
AMGEN INC.	+8.08%	167B
PFIZER, INC.	-3.40%	157B

Other Pharmaceuticals